My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 494

    1.

    Narrative review: the U.S. Pharmacopeia and model guidelines for Medicare Part D formularies.

    USP Model Guidelines Expert Committee; U.S. Pharmacopeia.

    Ann Intern Med. 2006 Sep 19;145(6):448-53. Review.PMID: 16983132 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    United States pharmacopeia development of the Medicare model formulary guidelines.

    Bielory L; USP Model Guidelines Expert Committee.

    Am J Geriatr Cardiol. 2005 Nov-Dec;14(6):301-7.PMID: 16276127 [PubMed - indexed for MEDLINE]Related articles

    3.

    The new medicare drug benefit: formularies and their potential effects on access to medications.

    Huskamp HA, Keating NL.

    J Gen Intern Med. 2005 Jul;20(7):662-5.PMID: 16050866 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.

    Kilian J, Stubbings J.

    J Manag Care Pharm. 2007 Jan-Feb;13(1):59-65. Review.PMID: 17269838 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Medicare Part D-a roundtable discussion of current issues and trends.

    Balfour DC 3rd, Evans S, Januska J, Lee HY, Lewis SJ, Nolan SR, Noga M, Stemple C, Thapar K.

    J Manag Care Pharm. 2009 Jan-Feb;15(1 Suppl A):3-9. Review.PMID: 19125555 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle.

    Andersen LS.

    Issue Brief Cent Medicare Educ. 2005;5(10):1-10.PMID: 15943013 [PubMed - indexed for MEDLINE]Related articles

    7.

    Grassley, CMS: USP classes won't get formulary a free pass.

    [No authors listed]

    Med Health. 2004 Oct 4;58(36):3-4. No abstract available. PMID: 15499734 [PubMed - indexed for MEDLINE]Related articles

    8.

    Medicare part D: selected issues for plan sponsors, pharmacists, and beneficiaries in 2008.

    Depue R, Stubbings J.

    J Manag Care Pharm. 2008 Jan-Feb;14(1):50-60. Review.PMID: 18240882 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Perverse incentives in the Medicare prescription drug benefit.

    McAdams D, Schwarz M.

    Inquiry. 2007 Summer;44(2):157-66.PMID: 17850042 [PubMed - indexed for MEDLINE]Related articles

    10.

    Guidelines for medication therapy management services in long-term care facilities.

    Medication Therapy Management Task Force, American Society of Consultant Pharmacists.

    Consult Pharm. 2007 Apr;22(4):355-61.PMID: 17658966 [PubMed - indexed for MEDLINE]Related articles

    11.

    Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disorders.

    Rosenberg JM.

    Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S18-23; quiz S24-5.PMID: 17215472 [PubMed - indexed for MEDLINE]Related articles

    12.

    Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.

    Thomas CP, Sussman J; Massachusettes Health Policy Forum; Massachusetts Medicaid Policy Institute.

    Issue Brief (Mass Health Policy Forum). 2007 May 30;(32):1-32.PMID: 17546802 [PubMed - indexed for MEDLINE]Related articles

    13.

    Medicare coverage for patients with diabetes. A national plan with individual consequences.

    Ashkenazy R, Abrahamson MJ.

    J Gen Intern Med. 2006 Apr;21(4):386-92.PMID: 16686819 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.

    Spooner JJ, Gandhi PK, Connelly SB.

    J Manag Care Pharm. 2007 Jan-Feb;13(1):37-43.PMID: 17269835 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The Medicare Prescription Drug Improvement and Modernization Act: prescription drugs and academic medicine.

    Frencher SK Jr, Glied S.

    Acad Med. 2006 Sep;81(9):812-6.PMID: 16936488 [PubMed - indexed for MEDLINE]Related articles

    16.

    Medicare Part D: an overview of its practical and clinical impact.

    Usdin S.

    Am J Geriatr Cardiol. 2005 Nov-Dec;14(6):284-8; quiz 289-90.PMID: 16276124 [PubMed - indexed for MEDLINE]Related articles

    17.

    A first look at the new Medicare prescription drug plans.

    Frakt AB, Pizer SD.

    Health Aff (Millwood). 2006 Jul-Aug;25(4):W252-61. Epub 2006 May 23.PMID: 16720588 [PubMed - indexed for MEDLINE]Related articles

    18.

    Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage.

    Cubanski J, Neuman P.

    Health Aff (Millwood). 2007 Jan-Feb;26(1):w1-12. Epub 2006 Nov 21.PMID: 17118944 [PubMed - indexed for MEDLINE]Related articles

    19.

    Diagnosis-based risk adjustment for medicare prescription drug plan payments.

    Robst J, Levy JM, Ingber MJ.

    Health Care Financ Rev. 2007 Summer;28(4):15-30.PMID: 17722748 [PubMed - indexed for MEDLINE]Related articles

    20.

    Medicare Part D: practical practice information for healthcare providers.

    Moczygemba LR.

    J Am Acad Nurse Pract. 2006 Oct;18(10):457-62. Review.PMID: 16999710 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity